Skip to main content
Article thumbnail
Location of Repository

Human airway smooth muscle promotion of mast cell survival and proliferation, and altered state of activation in asthma

By Fay Marie Hollins


Asthma is a condition that is characterized by variable airflow obstruction, airway hyperresponsiveness (AHR), chronic airway inflammation and airway remodeling. There is microlocalisation of mast cells within the airway smooth muscle (ASM) bundle in asthma at a level significantly above health and other respiratory diseases. These cells are recruited and their survival promoted. However, their functional consequences have yet to be discovered. AHR in asthma is a result of increased responsiveness of the ASM to agonist and has found to increase with localized mast cell numbers. This phenomenon could be a result of an intrinsic abnormality or of local effects. So far, it has yet to be elucidated. We sort to examine this phenomenon of the presence of mast cells within the ASM and the increased responsiveness of the ASM; mechanisms involved in sustaining mast cell numbers, and the intrinsic differences of ASM between asthma and health. \ud ASM had the ability to maintain survival and promote proliferation of co-cultured mast cells, a mechanism supported by the actions of stem cell factor (SCF), interleukin (IL)-6 and cell adhesion molecule (CADM)-1. There was a physical interaction in mast cell adhesion to ASM between CADM1 and the SCF receptor. The co-culture also enhanced constitutive mast cell degranulation. Intracellular calcium levels of ASM from asthmatic patients at rest were found to oscillate to a great degree. Following stimulation with agonist, the ASM gave a reduced intracellular calcium response. However, their contractile ability measured still remained greater than ASM isolated from non-asthmatic subjects. \ud SCF, IL-6 and CADM1 supported the survival of mast cells co-cultured with ASM. Although ASM from asthmatic subjects produce a reduced intracellular calcium response to agonist, at baseline these cells are more activated and they still retain their increased contractile response. Mechanisms which may contribute to the altered airway physiology in asthma

Publisher: University of Leicester
Year: 2009
OAI identifier:

Suggested articles


  1. (2008). A contraction assay system using established human bronchial smooth muscle cells. Int.Arch Allergy Immunol.
  2. (2004). A critical role for eosinophils in allergic airways remodeling.
  3. (1985). A new generation of Ca2+ indicators with greatly improved fluorescence properties.
  4. (1999). A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration.
  5. Activation of human lung mast cells by monomeric immunoglobulin E.
  6. (2007). Active monomers of human betatryptase have expanded substrate specificities.
  7. (2008). Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J.Allergy Clin.Immunol.
  8. (2000). Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
  9. (1996). Airway muscle stereology: implications for increased shortening in asthma.
  10. (2006). Airway remodeling and airway smooth muscle in asthma.
  11. (2004). Airway remodeling: a comparison between fatal and nonfatal asthma.
  12. (2006). Airway smooth muscle and asthma.
  13. (2006). Airway smooth muscle and mast cellderived CC chemokine ligand 19 mediate airway smooth muscle migration in asthma.
  14. (2005). Airway smooth muscle supports mast cell survival.
  15. (2004). Airway smooth muscle: the appendix of the lung.
  16. Airway structural alterations selectively associated with severe asthma.
  17. (1995). alphaThrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation.
  18. (2004). Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling.
  19. (2008). Approach to chronic obstructive pulmonary disease in primary care.
  20. (1973). Basophils in bronchial asthma with reference to reagin-type allergy.
  21. (2006). Biology of mast cell tryptase. An inflammatory mediator.
  22. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma.
  23. (2008). Calcium signaling in airway smooth muscle.
  24. (2003). Calcium signalling: dynamics, homeostasis and remodelling.
  25. (2008). Calponins: adaptable modular regulators of the actin cytoskeleton.
  26. (2005). CCR3 expression and function in asthmatic airway smooth muscle cells.
  27. (2005). CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J.Allergy Clin.Immunol.
  28. (1998). CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am.J.Respir.Crit Care Med.
  29. (1993). Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study.
  30. (2002). Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am.J.Physiol Lung Cell Mol.Physiol 283:L1181-L1189.
  31. (1996). Characteristics of histamine release from cultured human mast cells.
  32. (2005). Chemokine receptor expression by mast cells.
  33. (2003). Chemokines and cytokines: axis and allies in asthma and allergy. Cytokine Growth Factor Rev.
  34. (2001). Chemokines in cutaneous wound healing.
  35. (1998). Chemokines: understanding their role in T-lymphocyte biology.
  36. (2006). Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 129:116S-121S.
  37. (2006). Chronic obstructive pulmonary disease: current burden and future projections.
  38. (2007). Clinical relevance of airway remodelling in airway diseases.
  39. (2003). Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
  40. (2007). Comparison of gel contraction mediated by asthmatic and non-asthmatic airway smooth muscle cells.
  41. (2007). Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function.
  42. (2003). Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration.
  43. (2003). CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J.Allergy Clin.Immunol.
  44. (1997). Cytokine- and virusstimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines.
  45. (2006). Development, migration, and survival of mast cells.
  46. Diagnosis and management of adult asthma.
  47. (2006). Diagnostic value of tryptase in anaphylaxis and mastocytosis.
  48. (2005). Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration.
  49. (2001). Direct effects of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J.Respir.Crit Care Med.
  50. (2005). Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts.
  51. (2002). Distribution and degranulation of airway mast cells in normal and asthmatic subjects.
  52. (2008). Drugs for airway disease.
  53. (1997). Effects of salbutamol on intracellular calcium oscillations in porcine airway smooth muscle.
  54. (2004). Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J.Respir.Crit Care Med.
  55. (1999). Eosinophilic bronchitis is an important cause of chronic cough. Am.J.Respir.Crit Care Med.
  56. (2000). Eosinophilic bronchitis: an important cause of prolonged cough.
  57. (2006). Epidemiology of asthma.
  58. (2003). expression is co-localized to mast cells within the airway smooth muscle in asthma.
  59. (2003). Expression of connective tissue growth factor in asthmatic airway smooth muscle cells. Am.J.Respir.Crit Care Med.
  60. (2004). Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism. J.Allergy Clin.Immunol.
  61. (2006). Extracellular matrix regulates enhanced eotaxin expression in asthmatic airway smooth muscle cells. Am.J.Respir.Crit Care Med.
  62. (2002). FcepsilonRI signaling observed from the inside of the mast cell membrane.
  63. (2006). Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma.
  64. (2006). Functional K(Ca)3.1 K+ channels are required for human lung mast cell migration.
  65. (2006). Functional KCa3.1 K+ channels are required for human lung mast cell migration.
  66. (1993). Functional significance of increased airway smooth muscle in asthma and COPD.
  67. Heterogeneity of Human Mast-Cells Based on Cytokine Content.
  68. (1992). Histaminase activity in rat lung and its comparison with intestinal mucosal diamine oxidase.
  69. (2006). Histamine and its receptors.
  70. (1990). Histamine stimulates proliferation of airway smooth muscle and induces c-fos expression. Am J.Physiol 259:L365-L371.
  71. (2003). Histamine: A mediator of inflammation. J.Allergy Clin.Immunol.
  72. (2005). Human airway epithelial cell determinants of survival and functional phenotype for primary human mast cells.
  73. (2003). human asthmatic and nonasthmatic airway smooth muscle cells. Am.J.Physiol Lung Cell Mol.Physiol 285:L619-L627.
  74. (1999). Human bronchial smooth muscle cells in culture produce stem cell factor.
  75. (2000). Human endothelial cells regulate survival and proliferation of human mast cells.
  76. (2004). Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.
  77. (2006). Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1.
  78. (1991). Human mast cell carboxypeptidase. Selective localization to MCTC cells.
  79. (2005). Human mast cell chemokines receptors: implications for mast cell tissue localization in asthma.
  80. (1997). Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.
  81. (2007). Human mast cells, bacteria, and intestinal immunity.
  82. (2004). Human neutrophil-derived elastase induces airway smooth muscle cell proliferation. Life Sci.
  83. (2004). Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression.
  84. (1994). Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance.
  85. (2003). Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.
  86. (2008). IgE alone promotes human lung mast cell survival through the autocrine production of IL-6.
  87. (1995). IgE-dependent expression of mRNA for IL-4 and IL-5 in human lung mast cells.
  88. (2002). IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am.J.Physiol Lung Cell Mol.Physiol 282:L520-L528.
  89. (2008). Immunology of asthma and chronic obstructive pulmonary disease.
  90. (2003). Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cellcell adhesion and transmembrane protein localization in epithelial cells.
  91. (2002). Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma.
  92. (2006). Increased proinflammatory responses from asthmatic human airway smooth muscle cells in response to rhinovirus infection.
  93. (2004). Increased sensitivity of asthmatic airway smooth muscle cells to prostaglandin E2 might be mediated by increased numbers of E-prostanoid receptors. J.Allergy Clin.Immunol.
  94. (2008). Induced sputum and bronchial mucosal expression of interleukin-13 is not increased in chronic obstructive pulmonary disease.
  95. (1992). Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in longterm culture.
  96. (2007). Inflammation of bronchial smooth muscle in allergic asthma.
  97. (1998). Inflammatory mediators of asthma: an update.
  98. (1997). Inhibition of ERK activation attenuates endothelin-stimulated airway smooth muscle cell proliferation.
  99. (2003). Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. J.Allergy Clin.Immunol.
  100. (2006). Integrated signalling pathways for mast-cell activation.
  101. (2006). Interleukin-8: novel roles in human airway smooth muscle cell contraction and migration. Am.J.Physiol Cell Physiol 291:C957-C965.
  102. (1996). Intramural elastase injection increases responsiveness of isolated bronchial segments.
  103. (2001). Invited review: cross-bridge regulation by thin filament-associated proteins.
  104. (2005). Ion channels in smooth muscle: regulators of intracellular calcium and contractility. Can.J.Physiol Pharmacol.
  105. (1988). Leukotriene generation and metabolism in isolated human lung macrophages.
  106. (1998). Lung smooth muscle differentiation.
  107. (2001). Mast cell infiltration of airway smooth muscle defines the asthmatic phenotype.
  108. (2006). Mast cell mediators in allergic inflammation and mastocytosis.
  109. (2006). Mast cell migration to Th2 stimulated airway smooth muscle from asthmatics.
  110. (1997). Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J.Respir.Crit Care Med.
  111. (2007). Mast cell numbers in airway smooth muscle and PC20AMP in asthma and COPD.
  112. (2007). Mast cell tryptases and chymases in inflammation and host defense.
  113. (2007). Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation.
  114. (2008). Mast cells and mastocytosis.
  115. (2007). Mast cells as effector cells: a costimulating question. Trends Immunol.
  116. (2001). Mast cells as initiators of immunity and host defense.
  117. (2007). Mast cells in allergy: innate instructors of adaptive responses.
  118. (2008). Mast cells promote airway smooth muscle cell differentiation via autocrine up-regulation of TGF-beta1.
  119. (2002). Mast-cell infiltration of airway smooth muscle in asthma.
  120. (2006). Mechanisms of airway hyperresponsiveness. J.Allergy Clin.Immunol.
  121. (1996). Mechanisms of smooth muscle contraction. Physiol Rev.
  122. (1999). Mediators of inflammation and the inflammatory process. J.Allergy Clin.Immunol.
  123. (1983). Metabolism and function of gastric histamine in health and disease.
  124. (1994). Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle.
  125. (2008). Molecular mechanics of smooth muscle contractile proteins in airway hyperresponsiveness and asthma.
  126. (2006). Molecular mechanisms of mast cell development.
  127. (1993). Myosin isoform expression in developing and remodeling rat lung.
  128. (2004). Neutralizing endogenous IL-6 renders mast cells of the MCT type from lung, but not the MCTC type from skin and lung, susceptible to human recombinant IL-4-induced apoptosis.
  129. (2004). Neutrophilic infiltration within the airway smooth muscle in patients with COPD.
  130. (2003). New insights into the role of the mast cell in asthma.
  131. (2007). Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J.Allergy Clin.Immunol.
  132. (2007). Nox4 mediates TGF-beta1-induced retinoblastoma protein phosphorylation, proliferation, and hypertrophy in human airway smooth muscle cells. Am.J.Physiol Lung Cell Mol.Physiol 292:L1543-L1555.
  133. (2003). Observational study of the natural history of eosinophilic bronchitis.
  134. (2008). ORAI and store-operated calcium influx in human airway smooth muscle cells.
  135. (2001). p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 Mapk. Am.J.Physiol Cell Physiol 281:C123-C132.
  136. (2000). PAF, a putative mediator of oral inflammation.
  137. (2008). Pathogenesis of asthma.
  138. (2004). Pathophysiology of airflow limitation in chronic obstructive pulmonary disease.
  139. (1996). PDGF isoform-induced proliferation and receptor expression in human cultured airway smooth muscle cells. Am.J.Physiol 270:L415-L428.
  140. (2000). Phenotypic diversity and molecular mechanisms of airway smooth muscle proliferation in asthma.
  141. (2008). PKCdelta mediates thrombin-augmented fibroblastmediated collagen gel contraction.
  142. (1998). Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: role in mediating airway smooth muscle proliferation.
  143. (2004). Proliferative aspects of airway smooth muscle. J.Allergy Clin.Immunol.
  144. (2007). Prostaglandin receptor signaling in disease.
  145. (2005). Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response.
  146. (2007). Proximal signaling events in Fc epsilon RI-mediated mast cell activation. J.Allergy Clin.Immunol.
  147. (1999). Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry 36:340-
  148. (1992). Rabbit trachealis tension responses to receptor-mediated agonists are diminished by elastase.
  149. (1992). Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells.
  150. (2008). Reduced expression of the adhesion protein tensin1 in cultured human dermal fibroblasts affects collagen gel contraction.
  151. (2001). Regulation of the inflammatory response in asthma by mast cell products.
  152. (2001). Remodeling in asthma and chronic obstructive lung disease. Am J.Respir.Crit Care Med.
  153. (2003). Repeated allergen inhalation induces phenotypic modulation of smooth muscle in bronchioles of sensitized rats. Am.J.Physiol Lung Cell Mol.Physiol 284:L148-L159.
  154. (2008). Risk factors associated with irreversible airflow limitation in asthma. Curr.Opin.Allergy Clin.Immunol.
  155. (2007). Role of mast cells in airway remodeling.
  156. (2008). Role of non-kinase activity of myosin light-chain kinase in regulating smooth muscle contraction, a review dedicated to Dr. Setsuro Ebashi.
  157. (2002). Selective CCL5/RANTESinduced mast cell migration through interactions with chemokine receptors CCR1 and CCR4.
  158. (2003). SgIGSF: a new mast-cell adhesion molecule used for attachment to fibroblasts and transcriptionally regulated by MITF.
  159. (1998). Smooth muscle actin and myosin expression in cultured airway smooth muscle cells. Am.J.Physiol 274:L786-L792.
  160. (2003). Smooth muscle contraction and relaxation.
  161. (2000). Smooth muscle myosin heavy chain isoforms and their role in muscle physiology.
  162. Smooth muscle-specific alpha tropomyosin is a marker of fully differentiated smooth muscle in lung.
  163. (2000). Smooth-muscle myosin light-chain kinase content is increased in human sensitized airways.
  164. (2004). Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J.Allergy Clin.Immunol.
  165. (2001). Sputum, bronchoalveolar lavage and bronchial biopsy characteristics of eosinophilic bronchitis compared with asthma.
  166. (2005). Src is necessary and sufficient for human airway smooth muscle cell proliferation and migration.
  167. (1999). stimulates phosphatidylinositol 3-kinase in human airway smooth muscle cells. Am.J.Physiol 276:L246-L255.
  168. (2006). Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children.
  169. (1995). survival of cultured human mast cells.
  170. (2008). T cell trafficking in allergic asthma: the ins and outs.
  171. (2002). TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J.Allergy Clin.Immunol.
  172. (2000). The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin.
  173. (2005). The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am.J.Respir.Crit Care Med.
  174. (2005). The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy 60:1241-
  175. (2006). The global epidemiology of asthma in children. Int.J.Tuberc.Lung Dis.
  176. (2001). The human mast cell: functions in physiology and disease. Front Biosci.
  177. (1996). The instructive role of innate immunity in the acquired immune response.
  178. (2001). The mast cell in wound healing.
  179. (2008). The master switch: the role of mast cells in autoimmunity and tolerance.
  180. The nature of small-airway obstruction in chronic obstructive pulmonary disease.
  181. (1922). The pathology of bronchial asthma.
  182. (1992). The proliferative response of airway smooth muscle.
  183. (2004). The role of protease activation of inflammation in allergic respiratory diseases. J.Allergy Clin.Immunol.
  184. (2005). The role of Src family kinases in mast cell effector function.
  185. (1996). The seventransmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-Jun NH2-terminal kinase groups of mitogen-activated protein kinases.
  186. (2005). The spermatogenic Ig superfamily/synaptic cell adhesion molecule mast-cell adhesion molecule promotes interaction with nerves.
  187. (1993). The structure of large and small airways in nonfatal and fatal asthma. Am Rev.Respir.Dis.
  188. (2008). The Tec family kinase, IL-2-inducible T cell kinase, differentially controls mast cell responses.
  189. their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res.Rev.
  190. (2005). Therapeutic dosing with anti-interleukin-13 monoclonal antibody inhibits asthma progression in mice.
  191. (2006). Transforming growth factor-beta induces airway smooth muscle hypertrophy.
  192. (1991). Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant.
  193. (2007). TRPC channels as STIM1-regulated store-operated channels.
  194. (2001). Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells.
  195. (2003). Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis.
  196. (2002). Tryptase's potent mitogenic effects in human airway smooth muscle cells are via nonproteolytic actions. Am.J.Physiol Lung Cell Mol.Physiol 282:L197-L206.
  197. (2004). Where Do We Stand?: Asthma in the UK today.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.